First Trust Nasdaq Pharmaceuticals ETF (NASDAQ: FTXH)
Ticker | Name | Share % | |
---|---|---|---|
PFE | Pfizer, Inc. | 7.17% | |
ABBV | Abbvie Inc. | 7.18% | |
JNJ | Johnson & Johnson | 7.59% | |
BMY | Bristol-Myers Squibb Co. | 6.53% | |
MRK | Merck & Company, Inc. | 6.72% | |
UTHR | United Therapeutic | 4.02% | |
AMGN | Amgen Inc. | 3.77% | |
VRTX | Nvaesrtex Pharmaceuticals Inc | 4.02% | |
REGN | Regeneron Parmaceuticals Inc. | 3.93% | |
GILD | Gilead Sciences Inc | 3.88% | |
CAH | Cardinal Health Inc. | 4.32% | |
JAZZ | Jazz Pharmaceuticals Plc | 3.95% | |
LLY | Eli Lilly & Co. | 3.86% | |
ZTS | Zoetis Inc . | 4.07% | |
BIIB | Biogen Inc. Com | 3.61% | |
VTRS | Viatris | 3.84% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
FTXH suit un style d'investissement Large Cap Blend.
Les principales positions de FTXH incluent : PFE (7.17%), ABBV (7.18%), JNJ (7.59%), BMY (6.53%), MRK (6.72%). Il s'agit des plus grandes positions dans le portefeuille de l'ETF.
Les données du volume moyen quotidien pour FTXH ne sont actuellement pas disponibles.